Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Interleukin-1 in cancer therapy]

K Kawai1, K Aihara, S Nakai

  • 1Cellular Technology Institute, Otsuka Pharmaceutical Co., Ltd.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|March 1, 1994
PubMed
Summary

Interleukin-1 (IL-1) beta shows direct anti-tumor effects and stimulates immune responses for cancer therapy. It also enhances hematopoietic activity, aiding recovery in myelosuppressed patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Detection of current-sheet and bipolar ion flows in a self-generated antiparallel magnetic field of laser-produced plasmas for magnetic reconnection research.

Physical review. E·2022
Same author

Author Correction: Direct observations of pure electron outflow in magnetic reconnection.

Scientific reports·2022
Same author

High-power laser experiment on developing supercritical shock propagating in homogeneously magnetized plasma of ambient gas origin.

Physical review. E·2022
Same author

Direct observations of pure electron outflow in magnetic reconnection.

Scientific reports·2022
Same author

High-power laser experiment forming a supercritical collisionless shock in a magnetized uniform plasma at rest.

Physical review. E·2022
Same author

Reconstructing bifurcation diagrams only from time-series data generated by electronic circuits in discrete-time dynamical systems.

Chaos (Woodbury, N.Y.)·2020

Area of Science:

  • Immunology
  • Oncology
  • Hematology

Context:

  • Interleukin-1 (IL-1) is a cytokine with diverse biological functions.
  • Investigating IL-1's role in cancer therapy and hematopoietic recovery is crucial.

Purpose:

  • To evaluate the therapeutic potential of IL-1 beta in cancer treatment.
  • To assess IL-1 beta's immunostimulating and hematopoietic activities.

Summary:

  • IL-1 beta exhibits direct cytostatic effects on tumor cells in vitro.
  • In vivo studies showed IL-1 beta induced tumor regression and prolonged survival in mice via immune stimulation.
  • IL-1 beta accelerates granulocyte and platelet recovery by inducing colony-stimulating factors and stimulating hematopoietic progenitor cells.

Impact:

  • Phase II clinical trials demonstrate IL-1 beta efficacy against cutaneous T cell lymphoma (CTCL).
  • IL-1 beta has shown promise in accelerating hematologic recovery in myelosuppressed patients.
  • These findings support IL-1 beta as a potential therapeutic agent in oncology and supportive care.

Related Experiment Videos